North China Pharmaceutical Company.Ltd (SHA:600812)
China · Delayed Price · Currency is CNY 5.25
+0.03 (0.57%)
Apr 28, 2026, 3:00 PM CST
SHA:600812 Revenue
In the year 2025, North China Pharmaceutical Company.Ltd had annual revenue of 9.24B CNY, down -6.36%. North China Pharmaceutical Company.Ltd had revenue of 1.76B in the quarter ending December 31, 2025, a decrease of -23.93%.
Revenue
9.24B
Revenue Growth
-6.36%
P/S Ratio
1.02
Revenue / Employee
874.36K
Employees
10,000
Market Cap
9.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.24B | -627.92M | -6.36% |
| Dec 31, 2024 | 9.87B | -250.63M | -2.48% |
| Dec 31, 2023 | 10.12B | -379.75M | -3.62% |
| Dec 31, 2022 | 10.50B | 115.37M | 1.11% |
| Dec 31, 2021 | 10.38B | -1.11B | -9.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 27.28B |
| Harbin Pharmaceutical Group | 15.96B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Zhejiang Xianju Pharmaceutical | 3.76B |
| Beijing Foyou Pharma CO.,LTD | 3.49B |
| Jiuzhitang | 2.23B |